Mommy Makeover: Combined or Staged Surgery?

After pregnancy, some people consider surgery for changes in the abdomen and breasts. A ‘mommy makeover’ is a broad label, not one fixed operation: a plan may combine abdominoplasty with breast surgery and sometimes liposuction. The decision to do everything in one operation or divide procedures across separate dates affects the length and scope of each anaesthetic, the number of recoveries and the time before all areas have been treated. It also changes how complications should be counted. Research can inform that discussion, but the published comparisons do not answer every version of the combined-versus-staged question.

What the evidence can and cannot answer

Combining procedures may reduce the number of separate admissions, anaesthetic episodes and recovery periods. A staged plan divides the operative burden and may allow recovery between operations, but it involves another procedure and another recovery. Those are practical trade-offs, not proof that either pathway has a lower total risk. A fair comparison would follow similar patients through the complete planned pathway, count complications after every operation and define a common time horizon. Most available studies instead compare a combined operation with a single procedure, or describe selected patients who had operations at different stages.

There is also no single standard ‘mommy makeover’. A breast lift, implant procedure, reduction, abdominoplasty and liposuction have different operative demands and complication profiles. Registry estimates therefore cannot be transferred unchanged to a particular combination, surgeon, facility or patient. The most relevant question is not whether a label is safe in general, but how the proposed procedures and the person’s health, operative plan and recovery support fit together.

Why combining operations can change risk and recovery

Adding procedures in one session can mean more tissue dissection, more operative time and more than one healing area. These factors may affect bleeding, wound problems, infection, fluid collections, blood clots, anaesthetic planning and the ability to move comfortably after surgery. At the same time, staging adds a second exposure to surgery and anaesthesia and may extend the period before the overall plan is complete. Neither pathway removes risk; each distributes it differently.

Outcomes also depend on details that a general study label may conceal: which breast operation is planned, whether substantial liposuction is included, the amount of tissue removed, the patient’s health and body mass index, and how complications are defined and captured. A 30-day registry endpoint records only a short period. It cannot describe all later healing, revisions, satisfaction or the burden of a staged course. The available evidence supports individual assessment rather than a universal duration cut-off or a guarantee of a complication-free result.

A prospective study in women after pregnancy

Toto and colleagues prospectively enrolled 37 women at Campus Bio-Medico Hospital in Rome between October 2019 and January 2022. All were considered eligible for either abdominoplasty alone or a combined ‘mommy makeover’. After the options and their risks and benefits were discussed, participants chose the pathway: 18 had the combined group’s operation and 19 had abdominoplasty alone. This was a small, non-randomised comparison based on patient preference, not a trial of combined surgery against a planned staged programme.[1]

The authors assessed participants before and after surgery using the Body Uneasiness Test (including BUT-A), the Patient and Observer Scar Assessment Scale (POSAS), visual perception measures and questions about diastasis-related symptoms. Assessments were reported at nine months after surgery. In both groups, the abstract reports statistically significant pre-to-post changes in all observed BUT-A variables (p < 0.01). It describes diastasis-related symptom improvement as comparable and reports greater body-image improvement and overall satisfaction in the combined group. However, the accessible abstract does not provide the scale scores, between-group effect sizes, confidence intervals or numerical complication counts. A small sample cannot rule out clinically important differences in uncommon harms, and the abstract does not describe a prespecified non-inferiority margin. Its conclusion that safety was “not inferior” should therefore not be read as proof of equal safety.

This study is directly relevant to post-pregnancy patients and offers a nine-month patient-reported perspective, but its comparator was abdominoplasty alone. The study does not tell us whether the combined group would have had more or fewer complications than the same type of patients receiving breast and abdominal operations on separate dates. Choice of pathway may also reflect preferences or characteristics that influence outcomes, even when all participants were considered eligible for either option.

Large registries compare combined procedures with single procedures

Combined abdominal and breast operations in the TOPS registry

Khavanin and colleagues retrospectively analysed the American Society of Plastic Surgeons’ Tracking Operations and Outcomes for Plastic Surgeons (TOPS) registry. The study included 58,756 women who had abdominoplasty, panniculectomy, breast augmentation and/or mastopexy; 3,693 were recorded in the combined abdominal-and-breast group, 10,440 in the abdominal group and 44,623 in the breast group. Complications were assessed within 30 days, and logistic regression adjusted for recorded patient and procedure factors.[2]

The paper’s abstract reports complications in 9.40% of combined cases, compared with 9.75% of abdominal cases (p = 0.530) and 2.66% of aesthetic breast cases (p < 0.001). In the full-text table, the combined group’s ‘any complication’ figure is 9.91%; the abstract and table therefore give different values for that group. The adjusted analysis found breast-only surgery associated with lower odds than the combined group (OR 0.31, 95% CI 0.27–0.36, p < 0.001), while the abdominal-only group did not differ significantly from combined surgery (OR 0.87, 95% CI 0.75–1.01, p = 0.076). These are comparisons with single-operation registry groups, not with patients completing a staged plan.

The study also built a pretreatment score from diabetes, age over 53, obesity and ASA physical-status class 3 or higher. The abstract reports complication rates of 9.78% for the zero-point group, 16.63% for scores of 1–3 and 38.46% for scores of 4–7. The full-text table reports different percentages for the low- and medium-risk groups; rather than reconcile unlike source views without enough information, this account does not rely on those two strata. The highest-risk stratum contained only 13 cases, making its 38.46% estimate especially unstable. None of these historical registry figures is an individual prediction or a substitute for current clinical assessment. The registry reflects participating surgeons’ reported data and 30-day outcomes, and the paper labels its evidence level 4. It does not measure all later outcomes or account for every difference between people selected for each procedure.

A later TOPS analysis shows why the exact combination matters

Schafer and colleagues used TOPS records from 2016–2020 in a retrospective cohort analysis of five index procedures and their common combinations. The abstract reports 1,400 complications among 26,771 patients within 30 days and labels this 5.0% overall; the article retains that source-reported percentage without recalculating it. Across the included combinations, complication rates were 7.6% versus 4.2% for combination versus index procedures; the adjusted odds ratio was 1.91 (95% CI 1.61–2.27, p < 0.001). But the procedure-specific results were not uniform: adjusted rates for abdominoplasty combinations were not significantly different from abdominoplasty alone, whereas trunk-liposuction combinations and augmentation-mammaplasty combinations had higher adjusted complication odds than their respective index procedures. For augmentation combinations the adjusted OR was 1.60 (95% CI 1.13–2.22, p = 0.007); for trunk-liposuction combinations it was 4.84 (95% CI 3.31–7.21, p < 0.001).[3]

In this paper’s subgroup breakdown, augmentation combinations had 2.1% minor and 1.8% major complications, compared with 0.8% and 1.4% for augmentation alone. Trunk-liposuction combinations had 9.2% minor and 2.0% major complications, compared with 1.7% and 0.4% for trunk liposuction alone. The authors found no significant difference for abdominoplasty combinations, but the index abdominoplasty sample was the smallest of the five index groups (1,150). The outcomes were surgeon-reported, procedure categories relied on billing codes, and the data cannot reveal why each operation was combined or the full clinical details. This analysis reinforces that the components of a proposed plan matter; it does not establish the safety of every mommy-makeover combination or compare combined with staged care.

What studies of staged operations add

Coon and colleagues followed a prospective clinical database over five years at a high-volume centre, covering 609 people after massive weight loss. They reported 661 operative cases involving 1,070 procedures across breast, abdomen, thigh, buttock/lateral thigh, upper-back and arm categories. Length of stay increased with the number of procedures in a session (p < 0.001). Sixty cases were second-stage operations; the abstract says their complication rates and length of stay were similar to those of other cases. Seroma and wound dehiscence were associated with the number of procedures (p < 0.001), and tissue necrosis and infection were also associated (p = 0.02); haematoma was not (p = 0.25). Major complications did not increase in multiple-procedure cases.[4]

This paper is useful because it includes actual staged cases, but it concerns body contouring after massive weight loss rather than a postpartum cohort. Its abstract does not give the absolute complication rates for first- and second-stage pathways or a patient-level comparison of the total risk across all planned operations. The authors describe carefully selected patients at a high-volume centre. Those limitations prevent using the findings to claim that staging is safer, equally safe or less safe for a particular post-pregnancy plan.

How to read the combined-procedure evidence together

A 2026 systematic review and meta-analysis reports eight studies and a total of 138,020 patients, while listing 9,422 with concomitant abdominal and breast procedures, 11,700 with abdominoplasty alone and 106,898 with isolated breast surgery. Those three subgroup counts sum to 128,020, so the abstract’s overall denominator and its listed group totals do not reconcile; the available abstract does not explain the difference. The pooled overall comparison of combined with isolated procedures was not statistically significant (OR 1.11, 95% CI 0.63–1.96), with very high heterogeneity (I² = 97.9%). In subgroup analyses, the estimate versus abdominoplasty alone was OR 0.66 (95% CI 0.37–1.16), while the estimate versus breast surgery alone was OR 2.71 (95% CI 1.74–4.23). The authors rated certainty from moderate to very low and noted that database studies were highly heterogeneous.[5]

The wide overall interval is compatible with meaningfully lower or higher odds, and the high heterogeneity means studies did not estimate one consistent effect. The subgroup pattern is also unsurprising when a larger operation is compared with breast surgery alone, which may have a different baseline risk. The meta-analysis compares combined with isolated procedures; it does not compare combined surgery with a completed staged pathway. It therefore cannot settle the central question for someone choosing between one combined operation and two planned operations.

These studies also use different populations, procedure mixes, outcome definitions and follow-up periods. Some count all recorded complications, others separate minor and major events, and the prospective postpartum study emphasises patient-reported outcomes nine months after surgery. A 30-day rate should not be presented as a lifetime or full-recovery risk, and an observational association should not be treated as proof that the procedure combination itself caused the difference. Selection of healthier patients for longer combined operations can make combined care appear safer; conversely, adding a higher-risk component can increase the observed rate. Confounding and coding cannot be fully removed by statistical adjustment.

Using the evidence in a consultation

For an individual, the clinical discussion should identify the exact operations under consideration, the expected operative duration and the health factors that affect anaesthetic, wound and clot risk. It should also cover what recovery would involve at home, who can help with daily tasks, and how a second operation would be planned if procedures are staged. Ask the surgeon to explain which published population most resembles the proposed plan and how the practice defines and records minor and major complications. If a percentage is quoted, ask for the denominator, follow-up period and whether it refers to the same procedures and patient profile.

• Which procedures would be performed together, and which could reasonably be separated?
• How would the planned operative time and the patient’s health history affect the recommendation?
• What complications are included in the quoted rate, and is it based on this exact combination?
• If staged, what is the proposed order and interval, and how are risks counted across both operations?
• What recovery help, follow-up and contingency arrangements are needed after each option?
• What findings would lead the team to stop, shorten or stage the planned operation?

People comparing practical quotes can review our mommy makeover cost in Turkey information; it is a planning resource, not a recommendation about suitability. Anyone considering an advertised mommy makeover package should separately clarify which procedures, clinical assessments, follow-up and recovery arrangements are included. Just Clinic Istanbul is an independent marketing and lead-generation platform, not a healthcare provider or medical tourism intermediary. Enquiries may be shared with authorised healthcare partners with your consent.

References

1. Toto V, Scarabosio A, Alessandri-Bonetti M, Albanese R, Persichetti P. Combined Surgery (Mommy-Makeover) Compared to Single Procedure (Abdominoplasty) in After-Pregnancy Women: A Prospective Study on Risks and Benefits. Aesthetic Plastic Surgery. First published online 23 August 2023; December 2023 issue, 47(6):2533–2542. doi: 10.1007/s00266-023-03579-6. PMID: 37612475.
2. Khavanin N, Jordan SW, Vieira BL, Hume KM, Mlodinow AS, Simmons CJ, Murphy RX Jr, Gutowski KA, Kim JYS. Combining abdominal and cosmetic breast surgery does not increase short-term complication rates: a comparison of each individual procedure and pretreatment risk stratification tool. Aesthetic Surgery Journal. Published online 9 July 2015; 35(8):999–1006. doi: 10.1093/asj/sjv087. PMID: 26163312; PMCID: PMC6296326.
3. Schafer RE, Blazel MM, Nowacki AS, Schwarz GS. Risk of Complications in Combined Plastic Surgery Procedures Using the Tracking Operations and Outcomes for Plastic Surgeons Database. Aesthetic Surgery Journal. Published online 5 June 2023; 43(11):1384–1392. doi: 10.1093/asj/sjad124. PMID: 37128702.
4. Coon D, Michaels J 5th, Gusenoff JA, Purnell C, Friedman T, Rubin JP. Multiple procedures and staging in the massive weight loss population. Plastic and Reconstructive Surgery. February 2010; 125(2):691–698. doi: 10.1097/PRS.0b013e3181c87b3c. PMID: 20124854.
5. Skorochod R, Wolf Y. Risk of Concomitant Abdominoplasty and Breast Surgery versus Isolated Procedures: A Systematic Review and Meta-analysis. Aesthetic Plastic Surgery. Published online 6 May 2026; 50(13):5013–5022. doi: 10.1007/s00266-026-05863-7. PMID: 42089979.